Already a member? Sign in
Celecoxib is a non-steroidal antiinflammatory used to relieve the pain, swelling and stiffness of osteoarthritis and adult rheumatoid arthritis; to treat of primary dysmenorrhea; and to reduce intestinal polyps in the inherited disorder adenomatous polyposis.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Pain | 195 | 64 |
|
|
|
|
|
| Arthritis pain | 148 | 39 |
|
|
|
|
|
| Fibromyalgia | 84 | 29 |
|
|
|
|
|
| Inflammation | 46 | 13 |
|
|
|
|
|
| Other | 40 | 12 |
|
|
|
|
|
| Spinal Stenosis | 25 | 3 |
|
|
See all 477 patients currently taking Celecoxib
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Celecoxib
| Stomach upset | 6 | |
|---|---|---|
| Headaches | 6 | |
| Stomach problems | 5 | |
| Stomach pain | 5 | |
| Mood swings | 4 | |
| Weight gain | 3 | |
| See all 50 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Celecoxib. See all 20 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 115 | ||
| Side effects too severe | 68 | ||
| Doctor's advice | 60 | ||
| Other | 35 | ||
| Expense | 26 | ||
| Personal research | 19 | ||
| Course of treatment ended | 17 | ||
| Change in health plan coverage | 6 | ||
| Not indicated | 3 |
Adherence
Taking treatment as prescribed
Adherence of Celecoxib
Always |
149 | 79% |
|
|---|---|---|---|
Usually |
20 | 11% |
|
Sometimes |
11 | 6% |
|
Never |
8 | 4% |
|
Burden
Difficulty being on treatment
Burden of Celecoxib
Very |
9 | 5% |
|
|---|---|---|---|
Somewhat |
11 | 6% |
|
A little |
24 | 13% |
|
Not at all |
144 | 77% |
|
Cost
Paid out of pocket
Cost of Celecoxib
$200+ |
2 | 2% |
|
|---|---|---|---|
$100-199 |
6 | 5% |
|
$50-99 |
23 | 20% |
|
$25-49 |
28 | 24% |
|
< $25 |
56 | 48% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 23, 2012.